Potent and polyfunctional hepatitis b core (hbc)/surface (hbs)-specific cd8+and cd4+t cell responses observed in adults with chronic hepatitis b (chb) following targeted immunotherapy consisting of viral vectors in heterologous prime-boost regimen and adjuvanted hbc/hbs proteins: results on step b cohort of a phase i/ii trial